Shares of Kura Oncology (NASDAQ:KURA) — a clinical-stage biopharmaceutical company that focuses on developing cancer treatments — were up by 42.6% as of 1:49 p.m. EDT on Tuesday. The company did not report any news, but its stock is probably …
See Original Article

With draft beer sales virtually zeroed out thanks to the mandated closure of on-premise drinking due to the coronavirus pandemic, Charleston-area brewers may soon have to dispose of full kegs of beer that have gone stale in distributors’ warehouses. “We’ve …
See Original Article

By Kathy Lien, Managing Director of FX Strategy for BK Asset Management. The US dollar traded sharply lower ahead of Wednesday’s first quarter GDP report and Federal Reserve monetary policy announcement. Consumer confidence also fell to its weakest …
See Original Article

The Securities and Exchange Commission continued its crackdown on companies making false claims relating to tests, treatments or equipment for COVID-19 on Tuesday, by bringing charges against Praxsyn Corp. and its chief executive over false …
See Original Article

WASHINGTON—Treasury Secretary Steven Mnuchin is seeking an apology to American taxpayers from large companies that sought coronavirus hardship funds intended for small businesses. “Some of these companies should be apologizing,” he said in an …
See Original Article